About this trial
The aim of this single-arm prospective, multicenter, cross-sectional study is to evaluate the nutritional status and body composition on tumor regression grade with bioelectrical impedance analysis in gastric cancer patients undergoing multimodal treatment. Results of this study will reveal whether nutritional status and body composition assessment based on bioelectrical impedance analysis will become a validated and objective tool to support clinical decisions in gastric cancer patients undergoing multimodal treatment.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Histologically confirmed gastric adenocarcinoma (or undifferentiated carcinoma)
Stage II - III disease (cT2 cN+ and cT3-T4 cN+/-) based on the 8th edition of TNM classification
Qualification for multimodal treatment by the decision of the multidisciplinary tumor board
Disqualifiers
Early gastric cancer (cT1N0-3M0) scheduled for endoscopic treatment by multidisciplinary team
Gastric stump carcinoma
Distant metastasis
Upfront surgery
Trial design
Treatments tested in this trial
- Observational Survey
Treatment groups
Sponsors and collaborators
Medical University of Lublin
Lead sponsor
Erasmus Medical Center
Collaborator
Ohio State University
Collaborator
Poznan University of Medical Sciences
Collaborator
Jagiellonian University
Collaborator